Quickly determine the Mantle Cell Lymphoma International Prognostic Index (MIPI) score. This essential tool helps clinicians assess prognosis and stratify risk for patients with MCL based on key clinical factors, aiding treatment decisions and understanding expected outcomes.
Formula:
The MIPI score is a prognostic tool for Mantle Cell Lymphoma, calculated by assigning points to specific clinical risk factors:
- Age > 60 years: 1 point
- ECOG Performance Status ≥ 2: 1 point
- LDH Level Elevated: 1 point
- WBC Count Elevated: 1 point
- Bone Marrow Involvement: 1 point
Total MIPI Score = Sum of all applicable points (0-5)
Risk Stratification and Approximate Median Survival:
- Low Risk: 0-1 point (Median Survival: Approximately 8-10 years)
- Intermediate Risk: 2 points (Median Survival: Approximately 4-5 years)
- High Risk: 3-5 points (Median Survival: Approximately 1-2 years)